Avalo Therapeutics, Inc. (AVTX)
11.58
+0.31
(+2.75%)
USD |
NASDAQ |
Oct 19, 16:00
11.58
0.00 (0.00%)
After-Hours: 16:21
Avalo Therapeutics Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2025 | -23.25K% |
| September 30, 2025 | |
| June 30, 2025 | |
| March 31, 2025 | |
| December 31, 2024 | -18.41K% |
| September 30, 2024 | |
| June 30, 2024 | |
| March 31, 2024 | |
| December 31, 2023 | -1.43K% |
| September 30, 2023 | -2.22K% |
| June 30, 2023 | -1.27K% |
| March 31, 2023 | -2.10K% |
| December 31, 2022 | -1.10K% |
| September 30, 2022 | 21.35% |
| June 30, 2022 | -1.26K% |
| March 31, 2022 | -1.88K% |
| December 31, 2021 | -8.74K% |
| September 30, 2021 | -1.29K% |
| June 30, 2021 | -511.9% |
| Date | Value |
|---|---|
| March 31, 2021 | -6.46K% |
| December 31, 2020 | -1.08K% |
| September 30, 2020 | -1.19K% |
| June 30, 2020 | -958.7% |
| March 31, 2020 | -804.5% |
| September 30, 2019 | -133.1% |
| June 30, 2019 | -182.8% |
| March 31, 2019 | -200.4% |
| December 31, 2018 | -144.8% |
| September 30, 2018 | -603.8% |
| June 30, 2018 | -125.5% |
| March 31, 2018 | -86.62% |
| December 31, 2017 | -321.8% |
| September 30, 2017 | 74.77% |
| June 30, 2017 | -1.14K% |
| March 31, 2017 | -510.3% |
| December 31, 2016 | -900.5% |
| September 30, 2016 | -1.92K% |
| June 30, 2016 | -541.8% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| AbbVie, Inc. | 21.21% |
| Rezolute, Inc. | -- |
| ACADIA Pharmaceuticals, Inc. | 10.23% |
| Alnylam Pharmaceuticals, Inc. | 12.74% |
| Anika Therapeutics, Inc. | 10.15% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -63.01% |
| Return on Assets | -52.25% |
| Return on Invested Capital | -62.06% |
| Return on Net Operating Assets | -914.4% |